Compare Stocks

Aben Minerals Ltd. engages in the acquisition and exploration of mineral properties primarily in British Columbia, Saskatchewan, and Yukon, Canada. The company primarily explores for gold and graphite deposits. Its flagship project is the Forrest Kerr Gold project that covers an area of 23,397 hectares located in northwestern British Columbia. The company was formerly known as Aben Resources Ltd. and changed its name to Aben Minerals Ltd. in February 2023. Aben Minerals Ltd. was incorporated in 1960 and is headquartered in Vancouver, Canada.

Toubani Resources Inc. engages in the exploration and development of gold properties in West Africa. It focuses on the Kobada Gold project located in Southern Mali. The company was formerly known as African Gold Group, Inc. and changed its name to Toubani Resources Inc. in June 2022. Toubani Resources Inc. was incorporated in 2002 and is headquartered in Toronto, Canada.

Alacer Gold Corp. engages in the mining, development, and exploration of mineral deposits in Turkey. It primarily holds an 80% interest in the Ãöpler gold mine that is located in the Erzincan Province, east-central Turkey. The company was incorporated in 1993 and is based in Denver, Colorado.

Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule EP4 antagonist to modulate the tumor microenvironment; and AN4005, an oral small-molecule PD-L1 inhibitor to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and APC modulator; AN1025, an oral small molecule degrader of ß-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was incorporated in 2018 and is based in Grand Cayman, the Cayman Islands.